181 related articles for article (PubMed ID: 33864919)
1. Age-stratified seroprevalence of vaccine-preventable infectious disease in Saravan, Southern Lao People's Democratic Republic.
Xaydalasouk K; Sayasinh K; Hübschen JM; Khounvisith V; Keomany S; Muller CP; Black AP
Int J Infect Dis; 2021 Jun; 107():25-30. PubMed ID: 33864919
[TBL] [Abstract][Full Text] [Related]
2. Serosurveillance of vaccine preventable diseases and hepatitis C in healthcare workers from Lao PDR.
Black AP; Vilivong K; Nouanthong P; Souvannaso C; Hübschen JM; Muller CP
PLoS One; 2015; 10(4):e0123647. PubMed ID: 25874696
[TBL] [Abstract][Full Text] [Related]
3. Susceptibility to Vaccine-Preventable Diseases in Four Districts of Xaysomboun Province, Lao People's Democratic Republic.
Virachith S; Lao M; Inthepphavong M; Inthalath S; Hübschen JM; Kounnavong S; Sayasone S; Black AP
Vaccines (Basel); 2022 Mar; 10(3):. PubMed ID: 35335095
[TBL] [Abstract][Full Text] [Related]
4. Seroprevalence of chronic hepatitis B virus infection and immunity to measles, rubella, tetanus and diphtheria among schoolchildren aged 6-7 years old in the Solomon Islands, 2016.
Breakwell L; Anga J; Cooley G; Ropiti L; Gwyn S; Wannemuehler K; Woodring J; Ogaoga D; Martin D; Patel M; Tohme RA
Vaccine; 2020 Jun; 38(30):4679-4686. PubMed ID: 32473876
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of nationwide supplementary immunization in Lao People's Democratic Republic: Population-based seroprevalence survey of anti-measles and anti-rubella IgG in children and adults, mathematical modelling and a stability testing of the vaccine.
Hachiya M; Miyano S; Mori Y; Vynnycky E; Keungsaneth P; Vongphrachanh P; Xeuatvongsa A; Sisouk T; Som-Oulay V; Khamphaphongphane B; Sengkeopaseuth B; Pathammavong C; Phounphenghak K; Kitamura T; Takeda M; Komase K
PLoS One; 2018; 13(3):e0194931. PubMed ID: 29596472
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis B virus in the Lao People's Democratic Republic: a cross sectional serosurvey in different cohorts.
Black AP; Nouanthong P; Nanthavong N; Souvannaso C; Vilivong K; Jutavijittum P; Samountry B; Lütteke N; Hübschen JM; Goossens S; Quet F; Buisson Y; Muller CP
BMC Infect Dis; 2014 Aug; 14():457. PubMed ID: 25149478
[TBL] [Abstract][Full Text] [Related]
7. Seroprevalences of antibodies against pertussis, diphtheria, tetanus, measles, mumps and rubella: A cross-sectional study in children following vaccination procedure in Guangzhou, China.
Li YT; Luo XQ; Zhong XB; Cai LM; Zhu LP; Chen XQ; Wang KC; Chen ZG
Vaccine; 2020 May; 38(23):3960-3967. PubMed ID: 32321685
[TBL] [Abstract][Full Text] [Related]
8. Seroprevalence of Measles, Rubella, Tetanus, and Diphtheria Antibodies among Children in Haiti, 2017.
Minta AA; Andre-Alboth J; Childs L; Nace D; Rey-Benito G; Boncy J; Adrien P; Francois J; Phaïmyr Jn Charles N; Blot V; Vanden Eng J; Priest JW; Rogier E; Tohme RA
Am J Trop Med Hyg; 2020 Oct; 103(4):1717-1725. PubMed ID: 32618256
[TBL] [Abstract][Full Text] [Related]
9. Seroprotection at Different Levels of the Healthcare System After Routine Vaccination With Diphtheria-Tetanus-Pertussis whole cell-Hepatitis B-Haemophilus influenzae Type B in Lao People's Democratic Republic.
Hefele L; Syphan S; Xayavong D; Homsana A; Kleine D; Chanthavilay P; Nouanthong P; Xaydalasouk K; Phathammavong O; Billamay S; Xeuatvongsa A; Reinharz D; Muller CP; Black AP
Clin Infect Dis; 2019 Nov; 69(12):2136-2144. PubMed ID: 30778522
[TBL] [Abstract][Full Text] [Related]
10. Are we hitting immunity targets? The 2006 age-specific seroprevalence of measles, mumps, rubella, diphtheria and tetanus in Belgium.
Theeten H; Hutse V; Hens N; Yavuz Y; Hoppenbrouwers K; Beutels P; Vranckx R; Van Damme P
Epidemiol Infect; 2011 Apr; 139(4):494-504. PubMed ID: 20587123
[TBL] [Abstract][Full Text] [Related]
11. Vaccination coverage survey and seroprevalence among forcibly displaced Rohingya children, Cox's Bazar, Bangladesh, 2018: A cross-sectional study.
Feldstein LR; Bennett SD; Estivariz CF; Cooley GM; Weil L; Billah MM; Uzzaman MS; Bohara R; Vandenent M; Adhikari JM; Leidman E; Hasan M; Akhtar S; Hasman A; Conklin L; Ehlman D; Alamgir A; Flora MS
PLoS Med; 2020 Mar; 17(3):e1003071. PubMed ID: 32231368
[TBL] [Abstract][Full Text] [Related]
12. Timeliness of immunisation with the pentavalent vaccine at different levels of the health care system in the Lao People's Democratic Republic: A cross-sectional study.
Hefele L; Syphan S; Xayavong D; Homsana A; Kleine D; Chanthavilay P; Nouanthong P; Xaydalasouk K; Phathammavong O; Billamay S; Xeuatvongsa A; Reinharz D; Black AP; Muller CP
PLoS One; 2020; 15(12):e0242502. PubMed ID: 33290386
[TBL] [Abstract][Full Text] [Related]
13. Seroprevalence of vaccine-preventable diseases among children and adolescents in Singapore: Results from the National Paediatric Seroprevalence Survey 2018.
Ng Y; Chua LAV; Cui L; Ang LW; Tee NWS; Lin RTP; Ma S; Lee VJM
Int J Infect Dis; 2020 Mar; 92():234-240. PubMed ID: 31843668
[TBL] [Abstract][Full Text] [Related]
14. Seroprevalence of measles and rubella antibodies in vaccinated and unvaccinated infants in the Lao People's Democratic Republic.
Hefele L; Xaydalasouk K; Kleine D; Homsana A; Xayavong D; Syphan S; Hübschen JM; Muller CP; Black AP
Int J Infect Dis; 2021 Jul; 108():524-530. PubMed ID: 34119678
[TBL] [Abstract][Full Text] [Related]
15. Low and disparate seroprotection after pentavalent childhood vaccination in the Lao People's Democratic Republic: a cross-sectional study.
Evdokimov K; Sayasinh K; Nouanthong P; Vilivong K; Samountry B; Phonekeo D; Strobel M; Haegeman F; Heimann P; Muller CP; Black AP
Clin Microbiol Infect; 2017 Mar; 23(3):197-202. PubMed ID: 27756713
[TBL] [Abstract][Full Text] [Related]
16. Immunity against measles, mumps, rubella, varicella, diphtheria, tetanus, polio, hepatitis A and hepatitis B among adult asylum seekers in the Netherlands, 2016.
Freidl GS; Tostmann A; Curvers M; Ruijs WLM; Smits G; Schepp R; Duizer E; Boland G; de Melker H; van der Klis FRM; Hautvast JLA; Veldhuijzen IK
Vaccine; 2018 Mar; 36(12):1664-1672. PubMed ID: 29454516
[TBL] [Abstract][Full Text] [Related]
17. Seroprevalence and vaccination coverage of vaccine-preventable diseases in perinatally HIV-1-infected patients.
Sticchi L; Bruzzone B; Caligiuri P; Rappazzo E; Lo Casto M; De Hoffer L; Gustinetti G; Viscoli C; Di Biagio A
Hum Vaccin Immunother; 2015; 11(1):263-9. PubMed ID: 25483544
[TBL] [Abstract][Full Text] [Related]
18. Serologic testing of randomly selected children after hepatitis B vaccination: a cross-sectional population-based study in Lao People's Democratic Republic.
Norizuki M; Kitamura T; Komada K; Sugiyama M; Mizokami M; Xeuatvongsa A; Som-Oulay V; Vongphrachanh P; Machida M; Wada K; Ishii K; Kiyohara T; Wakita T; Hachiya M
BMC Infect Dis; 2019 Jun; 19(1):507. PubMed ID: 31182043
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis A Virus in Lao People's Democratic Republic: Seroprevalence and Risk Factors.
Khounvisith V; Xaiyaphet X; Chanthavilay P; Nouanthong P; Vongphachanh B; Reinharz D; Muller CP; Black AP
Am J Trop Med Hyg; 2020 Jul; 103(1):164-168. PubMed ID: 32342836
[TBL] [Abstract][Full Text] [Related]
20. The determinants of immunization coverage among children aged between 12 and 35 months: a nationwide cross-sectional study in Lao People's Democratic Republic.
Ichimura Y; Yanagisawa N; Thandar MM; Pathammavong C; Phounphenghuk K; Nouanthong P; Tengbriacheu C; Khamphaphongphane B; Franzel-Sassanpour LE; Yang TU; Raaijmakers H; Ota T; Komada K; Hachiya M; Miyano S
BMC Public Health; 2022 Dec; 22(1):2259. PubMed ID: 36463130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
